Morgan Stanley’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $471K | Sell |
98,476
-23,251
| -19% | -$128K | ﹤0.01% | 5515 |
|
|
2025
Q4 | $657K | Buy |
121,727
+58,051
| +91% | +$263K | ﹤0.01% | 5378 |
|
|
2025
Q3 | $311K | Sell |
63,676
-15,877
| -20% | -$84.2K | ﹤0.01% | 5713 |
|
|
2025
Q2 | $374K | Buy |
79,553
+10,082
| +15% | +$42.1K | ﹤0.01% | 5596 |
|
|
2025
Q1 | $254K | Sell |
69,471
-28,074
| -29% | -$128K | ﹤0.01% | 5636 |
|
|
2024
Q4 | $460K | Sell |
97,545
-10,656
| -10% | -$77.6K | ﹤0.01% | 5447 |
|
|
2024
Q3 | $1.01M | Buy |
108,201
+43,103
| +66% | +$312K | ﹤0.01% | 5035 |
|
|
2024
Q2 | $374K | Sell |
65,098
-9,872
| -13% | -$58.8K | ﹤0.01% | 5424 |
|
|
2024
Q1 | $503K | Sell |
74,970
-135,256
| -64% | -$751K | ﹤0.01% | 5305 |
|
|
2023
Q4 | $1.36M | Buy |
210,226
+137,979
| +191% | +$595K | ﹤0.01% | 5160 |
|
|
2023
Q3 | $361K | Sell |
72,247
-16,121
| -18% | -$124K | ﹤0.01% | 5311 |
|
|
2023
Q2 | $622K | Sell |
88,368
-5,199
| -6% | -$36.4K | ﹤0.01% | 5108 |
|
|
2023
Q1 | $580K | Sell |
93,567
-207,999
| -69% | -$1.36M | ﹤0.01% | 5167 |
|
|
2022
Q4 | $1.92M | Sell |
301,566
-734,549
| -71% | -$5.54M | ﹤0.01% | 4497 |
|
|
2022
Q3 | $8.89M | Sell |
1,036,115
-185,347
| -15% | -$2.39M | ﹤0.01% | 3105 |
|
|
2022
Q2 | $16.6M | Buy |
1,221,462
+192,736
| +19% | +$2.49M | ﹤0.01% | 2490 |
|
|
2022
Q1 | $15.7M | Buy |
1,028,726
+476,821
| +86% | +$6.54M | ﹤0.01% | 2381 |
|
|
2021
Q4 | $12.6M | Sell |
551,905
-427,322
| -44% | -$6.14M | ﹤0.01% | 2675 |
|
|
2021
Q3 | $13.6M | Sell |
979,227
-982
| -0.1% | -$10.9K | ﹤0.01% | 2543 |
|
|
2021
Q2 | $10.5M | Buy |
980,209
+586,487
| +149% | +$6.39M | ﹤0.01% | 2922 |
|
|
2021
Q1 | $5.19M | Buy |
393,722
+350,978
| +821% | +$5.75M | ﹤0.01% | 3367 |
|
|
2020
Q4 | $867K | Buy |
+42,744
| New | +$819K | ﹤0.01% | 4749 |
|
Other funds holding FHTX
FP
BI
DM
EC
VCM
SL